The London Inherited Cardiac Conditions Meeting: ‘ICC Genomics and Novel Therapies’ 2026

A one-day course offering the latest insights into genomics, novel treatments, and genetic testing approaches shaping the future of inherited cardiac disease care

Programme overview

This one-day course will provide attendees with updates in Inherited Cardiac Conditions with a focus on genomics and novel therapies for inherited cardiac disease.

Course aims/objectives

By the end of the meeting attendees will:

Who should attend

This in person meeting will bring together healthcare professionals working, training, and interested in inherited cardiac disease from Greater London and the South East region. All are welcome. This is a great opportunity to learn whilst networking with colleagues and friends.

Latest agenda

08:00

Breakfast / registration

09:00

Welcome and Updates from the ODN ICC Workstreams

  • Prof Perry Elliott and Prof Gerry Carr-White

Session 1

  • Chairs: Gerry Carr-White and Frances Elmslie (TBC)

09:15

Genetic testing for ICC in the London and South East England: The past 5 years

  • Dr Debbie Morris-Rosendahl, Royal Brompton Hospital

09:35

Genetic testing in sports cardiology: Who can play and who shouldn’t?

  • Prof Michael Papadakis, St George’s Hospital

09:55

Polygenic scores for diagnosis

  • Prof James Ware, Royal Brompton Hospital

10:15

Familial hypercholesterolaemia: Testing criteria and novel therapies

  • Prof Riyaz Patel, Bart’s Heart Centre

10:35

Panel discussion

10:50

Coffee

Session 2

  • Chairs: Maite Tome and Rachel Bastiaenen

11:20

Pharmacological provocation testing in ICC

  • Prof Pier Lambiase, Bart’s Heart Centre

11:40

Real-world experience with Mavacamten

  • Prof Rob Cooper, Liverpool Heart and Chest Hospital

12:00

HTAD: Genotype tailored management

  • Dr Leema Robert, Guy’s and St Thomas’ NHS Foundation Trust

12:20

Diagnosing DCM: Does sex matter?

  • Dr Paz Tayal, Royal Brompton Hospital

12:40

Panel discussion

12:55

Lunch

Session 3

  • Chairs: Sam Mohiddin (TBC) and Kostas Savvatis

13:55

Novel TTR amyloid therapies: A paradigm for precision medicine

  • Dr Jason Dungu, Essex Cardiothoracic Centre

14:15

Risk assessment in arrhythmogenic cardiomyopathy in the era of risk calculators

  • Dr Antonis Pantazis, Royal Brompton Hospital

14:35

Hypertrophic cardiomyopathy: Clinical trials and novel therapies

  • Prof Perry Elliott, Bart’s Heart Centre

14:55

Paediatric inherited arrhythmia syndromes

  • Dr Luke Starling, Great Ormond Street Hospital

15:15

Panel discussion

15:30

Coffee

MDT Cases

16:00

Panel and Cases TBC

17:00

Meeting Close

How to book

Book now via Eventbrite

Booking will be open soon. To register your interest email [email protected]